It has already been shown that gastric acidity in neonates is lower on day 4 of life than at birth (Miller, 1941) . Recent studies, however, have revealed that the fourth day plasma gastrin level is higher than at birth (Rogers et al., 1974) . A similar rise in glucagon plasma levels has occurred by day 4 and may act to inhibit the gastric secretory effect of the raised gastrin levels at that time (Rogers et al., 1974) .
Secretin also reduces acid response to gastrin (Johnson and Grossman, 1968) , and in this study we set out to see if a rise in plasma secretin levels on day 4 might also act to further inhibit the gastrininduced gastric acid secretion. There have been no previous recordings of secretin levels in the neonate.
Methods and materials
Maternal and cord venous samples were taken at birth from 22 mothers and babies (the same subjects which were studied in an earlier investigation: Rogers et al., 1974) . A further 3 ml venous sample was taken from 19 of these babies on day 4 after a 4-hour fast. 2 of the original babies were excluded because regular sedation with phenobarbitone had been required and one was excluded because of early discharge from hospital. The blood glucose was also measured in the cord and day 4 samples and informed consent was obtained from all the mothers studied.
Labour was spontaneous in 11 mothers and was induced by rupture of the membranes and intravenous infusion of oxytocin in 9 mothers. The remaining 2 mothers had an oxytocin infusion during the course of an otherwise spontaneous labour and were included in (Heding, 1971 by gastrin (Nakajima, Nakamura, and Magee, 1969; Johnson and Grossman, 1968) . Hence, the higher secretin levels on day 4 may act to inhibit the acid secretory effect of gastrin on day 4. A similar conclusion has been reached with respect to glucagon (Rogers et al., 1974) . The correlation between the maternal and cord levels suggests that secretin may be transferred across the placenta from mother to baby. Further studies are intended to clarify this point.
The inverse correlation between blood sugar concentration and plasma secretin levels on day 4 remains to be explained. There is abundant evidence that secretin stimulates insulin release (Unger et al., 1966; Jarret and Cohen, 1967; Deckert, 1968) , and that it may therefore be a hormone of importance in the entero-insular axis for glucose. Further support for this view came from Chisholm, Young and Lazarus (1969) , who found that plasma secretin levels rose after the ingestion of glucose. However, work from this laboratory has shown that plasma secretin levels fall after oral glucose in man (Buchanan et al., 1973) and are suppressed after intraduodenal or intravenous infusion of glucose in the dog (K. D. Buchanan unpublished). These conflicting results may be explained by different specificities of the two radioimmunoassays employed in these studies. Chis 
